UTR Therapeutics gets FDA orphan drug and rare pediatric disease designations for UTRxMYCN M1-14

UTR Therapeutics announced the U.S. FDA has granted an orphan drug designation and a rare pediatric disease designation for UTRxMYCN M1-14,